Carbenoxolone in the treatment of gastric ulcer.
D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D005753:Gastric Mucosa / Q000187:drug effects; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006035:Glycyrrhiza; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007785:Lactose / Q000627:therapeutic use; D010946:Plants, Medicinal; D013276:Stomach Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D013386:Succinates / Q000009:adverse effects / Q000627:therapeutic use; D013729:Terpenes / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014882:Water-Electrolyte Balance / Q000187:drug effects
D005765:Gastrointestinal Agents; D013386:Succinates; D013729:Terpenes; D007785:Lactose